Authors:
CALVO G
MORROS R
MATEU S
TORRES F
TORRENT J
JANE F
Citation: G. Calvo et al., ADVERSE DRUG-REACTIONS IN HIV-POSITIVE HOSPITALIZED-PATIENTS - A ONE-YEAR DRUG SURVEILLANCE PROGRAM - STUDY DESIGN, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 27-28
Citation: R. Morros, CPMP NOTE FOR GUIDANCE - CLINICAL INVESTIGATION OF ANTIANGINAL DRUGS IN STABLE ANGINA-PECTORIS, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 35-36
Authors:
MATEU S
MORROS R
FANJUL L
TORRES F
ALONSO M
JANE F
Citation: S. Mateu et al., DRUG PRESCRIPTION PROFILE TO PATIENTS WITH CHRONIC HEART-FAILURE VISITED IN OUR HOSPITAL, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 58-58
Citation: C. Vedia et R. Morros, CONSUMPTION PROFILE OF NONSTEROIDAL ANTI-INFLAMMATORY ANALGESIC AND ANTIULCER DRUGS IN A PRIMARY HEALTH-CARE AREA THROUGHOUT 1995 - CHANGESIN RELATION TO 1994/, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 78-78
Citation: R. Morros et C. Vedia, ANTIDEPRESSANT AND ANXIOLYTIC HYPNOTIC DRUG-USE IN CATALONIA THROUGHOUT 1991-1995/, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 79-79
Authors:
FRONTERA G
MATEU S
BARRIO JL
CLOPES A
FANJUL L
TORRES F
MORROS R
CALVO G
JANE F
Citation: G. Frontera et al., UTILIZATION OF 3RD GENERATION CEPHALOSPORINS WITHOUT ANTIPSEUDOMONAL ACTIVITY IN A TEACHING HOSPITAL, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 81-81
Authors:
CALVO G
MORROS R
MATEU S
FANJUL L
TORRES F
JANE F
Citation: G. Calvo et al., PATIENT CHARACTERISTICS AND DRUG PRESCRIPTION IN A HIV-POSITIVE PATIENTS MEDICAL WARD, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 82-82
Authors:
MATIASGUIU J
ALVAREZSABIN J
FERRO J
CALVO G
GALVE E
GOMEZ MD
IZQUIERDO I
MORROS R
NAVAS C
PAREDES I
TORRENT J
TORRES F
Citation: J. Matiasguiu et al., TRIFLUSAL ASPIRIN CEREBRAL INFARCTION PREVENTION (TACIP) STUDY - ONGOING CLINICAL-TRIAL, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 92-92